SimVantage

SimVantage

Biotechnologieforschung

Graz, Styria 765 Follower:innen

Reactor simulations made accurate, fast and easy.

Info

SimVantage stands for a next-generation, easy-to-use simulation software and profound expertise in the simulation-based design and optimization of gassed and/or stirred reactors. Our bioreactor simulation tool will provide you with unique insights. Easy to use for everyone.

Branche
Biotechnologieforschung
Größe
2–10 Beschäftigte
Hauptsitz
Graz, Styria
Art
Privatunternehmen
Gegründet
2021
Spezialgebiete
process optimization, scale up, chemical engineering, bioreactors, physics und simulation software

Orte

Beschäftigte von SimVantage

Updates

  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    🔬 Back from #ESBES 2024 in Copenhagen, and wow - what an event!   This year’s symposium highlighted the growing impact of #simulation in process development and optimization, underscoring just how essential it’s becoming for efficient and scalable bioprocessing. Here’s what stood out to us:   1. Simulation-Supported Process Development: Simulation took center stage as a tool for streamlining and optimizing complex processes. Industry leaders are experiencing firsthand how it reduces both time and costs, cutting down on repetitive lab work.   2. Gradients & Cellular Productivity Inhomogeneity: Understanding gradients and pinpointing productivity inhomogeneities in bioreactors is essential. By knowing where these variations occur, teams can design and operate reactors with precision - a capability our software delivers.   3. Compartment Models for Complex Biology: Simulating complex biological systems isn’t easy, but compartment models are making it possible. These models allow for capturing intricate biological behaviors with both efficiency and accuracy.   The response to our #software was overwhelmingly positive, with attendees eager to explore its potential! For many, our rigorous #validation process stood out as a game-changer, instilling confidence that our simulation results are both accurate and scalable - delivering reliable insights at any scale. 🚀   Seeing this enthusiasm reinforces our mission - validated simulations are the future of bioprocessing. Curious to see how we’re driving this growth? Let’s connect!  - P.S. Thanks to Eva-Maria Wlaschitz for capturing this moment on stage 📸

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    At #ESBES in Copenhagen, we are excited to introduce a brand-new approach to scale up processes - within seconds - without losing the advantage of validated, physics-based models.   Scaling bioprocesses from laboratory to production has traditionally been complex, time-consuming, and costly, often requiring empirical methods.   At SimVantage, we have worked diligently to incorporate feedback from our customers and partners. This collaborative effort has led to the development of an innovative solution, designed to transform how bioreactors are scaled with unmatched speed and accuracy.   🔍 How does it work? We will provide a detailed explanation in a future post, but here is a brief overview: Our solution combines advanced CFD simulations with machine learning, enabling rapid scale-up while maintaining the precision of validated, physics-first models.   💡 Join us for more insights! Christian Witz will be presenting the details tomorrow at the ESBES 2024 Symposium - don’t miss this opportunity: 🗓️ When: Tuesday, 22 October, 1:00–2:15 pm 📍 Where: Studio 3   For the full event schedule, check the ESBES 2024 program here: https://lnkd.in/dhAeNnGX - 👉 Follow SimVantage for the latest advancements in #bioreactor technologies and #simulationtools.

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    Biotech Summit Takeaways: Overcoming hurdles and strengthening networks 🤝 What a fantastic experience at the 2nd BIOTECH AUSTRIA Summit! 🧬 The event brought to light the immense complexity of bringing new therapies to market. From cutting-edge insights to innovative startup pitches, the summit was a whirlwind of inspiration and connection. Huge shout-out to our friends at QUBICON, especially Wolfgang Sommeregger, for delivering one of the most engaging pitches of the event. 🎤  Definitely a standout moment! 👏 The Hike ⛰️ and Dine ✨  event were an incredible icebreaker. It felt like a class reunion - catching up with familiar faces, exchanging ideas, and hearing about progress since we last met. Networking was effortless, especially because we all share the same challenges in bioprocessing and scaling up innovation. At SimVantage, we’re committed to tackling these challenges head-on. Whether it’s rapid tech transfer or bioreactor #optimization through our #simulationsoftware, we’re constantly pushing the envelope to help #biotech teams achieve their goals faster and more efficiently. ➡️ Were you at the Summit? We’d love to hear your key takeaways and discuss how simulation can help overcome the hurdles we face in bringing new therapies to market. Let’s keep the conversation going!

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    Looking Back at 2 inspiring days in France 🇫🇷 We had the honor of joining Ypso-Facto for their 10th-anniversary celebration during a two-day event in Nancy, France. Over the past decade, Ypso-Facto has been setting new standards for #biochemical #processdevelopment and #simulation, with advanced software like Ypso-Ionic and Proxima leading the way. They’ve transformed how companies #optimize and #scale processes, all while driving digital innovation. ✨ Event highlights: 👌 SimVantage was among 100 participants from 40 companies across 14 countries, representing the entire biopharma sector, including pharmaceutical companies, CDMOs, and suppliers. 👌 Distinguished speakers from major industry players such as Bachem, GSK, Sanofi, and Roche, alongside esteemed academic partners, shared their expertise. Their presentations showed how science and mechanistic modeling can revolutionize the design of upstream and downstream processes. 👌 What impressed us the most: a thought-provoking talk on the fascinating interplay between humans and robots in surgery. 🤖 The insights on robotic assistance reshaping routine tasks and training the next generation of surgeons were truly eye-opening. 👌 A gourmet buffet and an unforgettable gala dinner at the prestigious Hôtel de Ville de Nancy, with a breathtaking view of the world-renowned Place Stanislas. This event underscored the critical role of chromatography and simulation in biotech. We’re excited about the joint projects SimVantage and Ypso-Facto have in the works. 🔬 👉 Follow us for more updates on the latest in biotech innovation!

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

     Mission accomplished! Our CTO, Philipp Eibl, just accepted the CLAUS Award for the ECOnti consortium project - and in true James Bond style! 🤵♂️ Alongside Lejla Pock, they turned the latest issue of Botenstoff into an absolute highlight. But behind the glamor lies real innovation. The CLAUS Award celebrates standout cooperative projects within the Human.technology Styria GmbH (HTS) network. And that’s exactly what ECOnti is - a groundbreaking collaboration between Novasign, QUBICON, enGenes Biotech GmbH., Tosoh Bioscience, Inc., and us at SimVantage. ECOnti harnesses the power of digital twins to revolutionize continuous protein production. By simulating complex microbial processes, we’re making biotech more efficient, sustainable, and ready for future regulatory approvals. 🚀 Read the full article here: https://lnkd.in/dg2YgrET Want to stay up to date? 👉 Follow us - this is just the beginning of how collaboration drives innovation! #teamwork #digitaltwin #ECOnti #biotech #sustainability #CLAUSaward

    Unternehmensseite von Human.technology Styria GmbH anzeigen, Grafik

    3.119 Follower:innen

    Die Druckmaschinen laufen noch - aber online ist er schon da - der neue 🎉 𝗯𝗼𝘁𝗲𝗻𝘀𝘁𝗼𝗳𝗳 𝗢𝗸𝘁𝗼𝗯𝗲𝗿 𝟮𝟬𝟮𝟰🎉. Hier online durchblättern: https://lnkd.in/dg2YgrET In der Titelstory würdigen wir die CLAUS-Gewinner und überlegen gemeinsam mit prominenten Vertretern der Cluster Community, was eine erfolgreiche Kooperation ausmacht. Im Spezialteil werfen wir einen Blick auf kleine Organismen, die ein große Zukunft haben: Das Mikrobiom steht im Zentrum von vielen herausragenden Cluster-Unternehmen - allen voran: das Institut AllergoSan. Ein großer Dank gilt dem erweiterten Redaktions-Team: Anita Frauwallner, Institut AllergoSan | Alexander Rosenkranz, Katharina Lichtenegger, Christina Kumpitsch, Christine Moissl-Eichinger, Klara Filek Medizinische Universität Graz | Mathias Drexler, Birgit Wassermann, acib GmbH | Gerd Hartinger, Geriatrische Gesundheitszentren der Stadt Graz | Franz Feichtner, Christoph Magnes, JOANNEUM RESEARCH | Holzschlag Gerd, Steirische Wirtschaftsförderung SFG | Philipp Eibl, SimVantage | QUBICON | Novasign | Thomas Maischberger, ZETA | Gerold Meininger MEDS Spath Micro Electronic Design GmbH | Christian Schorn, Nutek | Claudia Grabner, Lactosan GmbH & Co KG | Katrin Susanna W., Lanbiotic | Berg Gabriele, Johanna Pirker, Technische Universität Graz | Oliver Wimmer, HerzensApp GmbH | Dalia Hämmerle, telbiomed Medizintechnik und IT Service GmbH | Christina Rupp, ICS Internationalisierungscenter Steiermark

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    Meet Lukas Gsenger - optimizing biotech with machine learning 👨💻 Today, we’re wrapping up our team spotlight series with Lukas - a bioreactor simulation expert whose skills are just as impressive as his passion for fitness and beach volleyball. 🏐 At SimVantage, Lukas is leading the development of surrogate models for the FFG Österreichische Forschungsförderungsgesellschaft mbH Lead Project. He’s combining machine learning with real-time simulation to optimize scale-up and scale-down processes, making our bioprocess solutions more efficient. What sets Lukas apart? It’s his curiosity and determination. He’s always looking for new ways to solve complex problems, constantly mastering new simulation techniques and expanding his knowledge. Lukas believes in the power of routine. His time in the gym provides balance, proving that small, incremental efforts lead to big results - a philosophy he applies both professionally and personally. In the summer, you’ll find Lukas on the beach volleyball court. In the winter, he’s hitting the slopes and he’s always up for a good coffee and deep conversations about science, society, or the universe. ☕️🌌 That’s why he loves attending conferences - exchanging ideas with brilliant minds like yours. 💬 Do you share a passion for bioreactors or the biotech industry? Let’s connect! 🤝

    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    Finally, conference season is back! Summer was nice, but autumn is even better—because it's time for conferences again! The RCPE - Research Center Pharmaceutical Engineering GmbH kicked things off with the #ECCPM 2024 last week in Graz, where the spotlight was on the latest advancements in pharmaceutical process modeling and development. SimVantage was excited to participate with our demo bioreactor, showcasing how our simulation software optimizes and scales bioreactor processes. Some attendees were a bit disappointed, though - they thought we were serving Aperol Spritz because the liquid in our bioreactor was orange! Unfortunately, no cocktails at our booth, but it was still a blast demonstrating how our technology works. The historic Old Technical University venue added a special touch, and it was great to see industry leaders like FDA, European Medicines Agency and Pfizer, Human.technology Styria GmbH, BNN - BioNanoNet in attendance. Huge shoutout to the RCPE - Research Center Pharmaceutical Engineering GmbH team for organizing such an incredible event!  👏 Looking forward to many more. 👉 Follow us for more updates on bioreactor innovations, process optimization, and upcoming events!

    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
    • Kein Alt-Text für dieses Bild vorhanden
  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    "Europe has largely missed out on the digital revolution and the productivity gains it brought," ...said Mario Draghi. But missed opportunities don’t have to stay that way. At SimVantage, we’re helping the #biotech industry catch up – and leap ahead 🚀 Let’s turn missed opportunities into success stories – are you in? Read the full article here: https://lnkd.in/dAtjc4xT #digitaltransformation #biotechinnovation #bioreactorsimulation #scaleup #processoptimization

    Draghi-Bericht: Europas Wirtschaft braucht Milliardenspritze

    Draghi-Bericht: Europas Wirtschaft braucht Milliardenspritze

    orf.at

  • Unternehmensseite von SimVantage anzeigen, Grafik

    765 Follower:innen

    Join the future of pharmaceutical manufacturing at ECCPM 2024! 🔔 Mark your calendars for September 11-12, 2024, and prepare to connect with leading experts in Graz, Austria, at the ECCPM Workshop organized by our valued partner, RCPE - Research Center Pharmaceutical Engineering GmbH. This event is a must-attend for anyone involved in #pharmaceuticalmanufacturing, from #molecules to advanced #therapies, and from #digitaltools to sophisticated hardware! What’s in store for you? Exclusive scientific training and expert panels: 📢 Day 1 kicks off with hands-on scientific training led by RCPE's top experts, diving deep into state-of-the-art continuous manufacturing practices. 📢 Day 2 brings a curated panel of international thought leaders who will guide discussions on implementing cutting-edge technologies in pharmaceutical manufacturing. Plus, an exclusive timeslot for exhibitors to showcase their innovations! 🌎 Key sessions to expand your horizons: - Advanced Continuous Drug Substance Manufacturing - Advanced Continuous Drug Product Manufacturing - Continuous Manufacturing of Nano-Structured Systems - Leveraging Modeling, Simulation, and Machine Learning 🗣 Network with the best: Join over 100 participants, including C-level executives, innovators, researchers, industry professionals, and regulatory agencies. This is your chance to engage in meaningful discussions, explore breakthrough approaches, and expand your professional network. 💡 Special highlight: Don’t miss the BioNanoNet Annual Forum on September 12th, focusing on “Sustainability in Pharma.” The event includes a joint afternoon session and a networking event, bringing together BioNanoNet members and partners. BioNanoNet members enjoy a 25% discount on the ECCPM Forum participation fee! 🎟 Register now and be part of this transformative event! Secure your spot today and step into the future of pharmaceutical production. Click here to register: https://lnkd.in/dwcy-J4z Let’s shape the future of pharma manufacturing - together! #pharmainnovation #continuousmanufacturing #pharmaceuticals #networking #ECCPM2024 #sustainabilityinpharma #bioreactorsimulation

Ähnliche Seiten